Obesity in cancer survival

Annual Review of Nutrition

Volumn 32, Issue , 2012, Pages 311-342

  Parekh, Niyati ^a   Chandran, Urmila ^b,c   Bandera, Elisa V ^b,c  

^a NEW YORK UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Adiposity; BMI; Breast cancer; Cancer prognosis; Colorectal cancer; Prostate cancer

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; INSULIN; LEPTIN; PROGESTERONE RECEPTOR; SOMATOMEDIN C; STEROID HORMONE; TAMOXIFEN;

BIOCHEMISTRY; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE FREE SURVIVAL; HUMAN; INFLAMMATION; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SYSTEMATIC REVIEW; WAIST HIP RATIO; WEIGHT CHANGE;

ADIPOSITY; BIOMEDICAL RESEARCH; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASMS; OBESITY; PROGNOSIS; PROSTATIC NEOPLASMS; RESEARCH DESIGN;

CITRUS MACROPHYLLA;

EID: 84864249770     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071811-150713     Document Type: Review

References (112)

1. Altekruse S, Kosary C, Krapcho M, Neyman N, Aminou R, Waldron W. 2010. SEER cancer statistics review, 1975-2008. Bethesda, MD: Natl. Cancer Inst. http://seer.cancer.gov/csr/1975-2007/
2. Am. Cancer Soc. 2011. Cancer Facts & Figures 2011. Atlanta, GA: Am. Cancer Soc. http://www.cancer. org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-029771.pdf
3. Am. Cancer Soc. 2011. Survival Rates for Breast Cancer. Atlanta, GA: Am. Cancer Soc. http://www.cancer.org/Cancer/BreastCancer/OverviewGuide/breast- cancer-overview-survival-rates
4. Barb D, Williams CJ, Neuwirth AK, Mantzoros CS. 2007. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am. J. Clin. Nutr. 86:858-66S
5. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, et al. 2009. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am. J. Obstet. Gynecol. 200:288.e1-8
6. Bastarrachea J, HortobagyiGN, Smith TL, Kau SW, Buzdar AU. 1994. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann. Intern. Med. 120:18-25 (Pubitemid 24011496)
7. Berclaz G, Li S, PriceKN, CoatesAS, Castiglione-Gertsch M, et al. 2004. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann. Oncol. 15:875-84 (Pubitemid 39004342)
8. Borugian MJ, Sheps SB, Kim-Sing C, Olivotto IA, Van Patten C, et al. 2003. Waist-to-hip ratio and breast cancer mortality. Am. J. Epidemiol. 158:963-68 (Pubitemid 37413395)
9. Caan BJ, Emond JA, Natarajan L, Castillo A, Gunderson EP, et al. 2006. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res. Treat. 99:47-57 (Pubitemid 44168602)
10. Caan BJ, Kwan ML, Hartzell G, Castillo A, Slattery ML, et al. 2008. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 19:1319-28
11. Calle EE, RodriguezC, Walker-Thurmond K, ThunMJ. 2003. Overweight, obesity, andmortality from cancer in a prospectively studied cohort of US adults. N. Engl. J. Med. 348:1625-38 (Pubitemid 36459468)
12. Cao Y, Ma J. 2011. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev. Res. 4:486-501
13. Carmichael AR. 2006. Obesity and prognosis of breast cancer. Obes. Rev. 7:333-40 (Pubitemid 44564304)
14. Chen X, Lu W, Zheng W, Gu K, Chen Z, et al. 2010. Obesity and weight change in relation to breast cancer survival. Breast Cancer Res. Treat. 122:823-33
15. Choi KM, Ryu OH, Lee KW, Kim HY, Seo JA, et al. 2007. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res. Clin. Pract. 75:235-40 (Pubitemid 44894605)
16. Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, et al. 2007. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol. Biomarkers Prev. 16:1803-11 (Pubitemid 47450510)
17. Cottin V, Arpin D, Lasset C, Cordier JF, Brune J, et al. 1999. Small-cell lung cancer: Patients included in clinical trials are not representative of the patient population as a whole. Ann. Oncol. 10:809-15 (Pubitemid 29367998)
18. Dal Maso L, Zucchetto A, Talamini R, Serraino D, Stocco CF, et al. 2008. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int. J. Cancer 123:2188-94
19. Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR. 2009. The impact of obesity on overall and cancer specific survival in men with prostate cancer. J. Urol. 182:112-17
20. Davies NJ, Batehup L, Thomas R. 2011. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br. J. Cancer 105(Suppl. 1):S52-73
21. Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, et al. 2008. Prognostic value of body mass index in locally advanced breast cancer. Clin. Cancer Res. 14:1718-25 (Pubitemid 351469456)
22. Desantis C, Siegel R, Bandi P, Jemal A. 2011. Breast cancer statistics, 2011. CA Cancer J. Clin. 61:409-18
23. Dignam J, Wieand K, Johnson K, Raich P, Anderson S, et al. 2006. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res. Treat. 97:245-54 (Pubitemid 43948218)
24. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, et al. 2006. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J. Natl. Cancer Inst. 98:1647-54 (Pubitemid 44811647)
25. Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP. 2003. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J. Natl. Cancer Inst. 95:1467-76 (Pubitemid 37279332)
26. Doria-Rose V, Newcomb P, Morimoto L, Hampton J, Trentham-Dietz A. 2006. Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control 17:63-70 (Pubitemid 43083671)
27. Efstathiou JA, Bae K, Shipley WU, Hanks GE, Pilepich MV, et al. 2007. Obesity and mortality in men with locally advanced prostate cancer. Cancer 110:2691-99 (Pubitemid 350250338)
28. Enger SM, Bernstein L. 2004. Exercise activity, body size and premenopausal breast cancer survival. Br. J. Cancer 90:2138-41 (Pubitemid 38869718)
29. Enger SM, Greif JM, Polikoff J, Press M. 2004. Body weight correlates with mortality in early-stage breast cancer. Arch. Surg. 139:954-58; discussion 958-60
30. Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, et al. 2011. Effect of obesity on prognosis after early-stage breast cancer. J. Clin. Oncol. 29:25-31
31. Fain JN, Madan AK, HilerML, Cheema P, Bahouth SW. 2004. Comparison of the release of adipokines by adipose tissue, adipose tissuematrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273-82 (Pubitemid 38535056)
32. Fantuzzi G. 2005. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115:911-19; quiz 920
33. Fischer S, HanefeldM, Haffner SM, Fusch C, SchwanebeckU, et al. 2002. Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol. 39:105-10
34. Flegal KM, Carroll MD, Ogden CL, Curtin LR. 2010. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-41
35. Frankenberry KA, Somasundar P, McFaddenDW, Vona-Davis LC. 2004. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am. J. Surg. 188:560-65 (Pubitemid 39491105)
36. Gong Z, Agalliu I, Lin DW, Stamford JL, Kristal AR. 2007. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 10:1192-202 (Pubitemid 46435400)
37. Halliwell B. 2007. Oxidative stress and cancer: Have we moved forward? Biochem. J. 401:1-11 (Pubitemid 46115897)
38. Harrop JP, Dean JA, Paskett ED. 2011. Cancer survivorship research: a review of the literature and summary of current NCI-designated cancer center projects. Cancer Epidemiol. Biomarkers Prev. 20:2042-47
39. Hausman GJ, Richardson RL. 2004. Adipose tissue angiogenesis. J. Anim. Sci. 82:925-34 (Pubitemid 38572359)
40. Haydon AMM, MacInnis RJ, English DR, Giles GG. 2006. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 55:62-67 (Pubitemid 41820637)
41. Hebert JR, Hurley TG, Ma Y. 1998. The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res. Treat. 51:17-28 (Pubitemid 28550157)
42. Hursting SD, Berger NA. 2010. Energy balance, host-related factors, and cancer progression. J. Clin. Oncol. 28:4058-65
43. Hursting SD, Lashinger LM, WheatleyKW, Rogers CJ, Colbert LH, et al. 2008. Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract. Res. Clin. Endocrinol. Metab. 22:659-69
44. Imkampe AK, Bates T. 2010. Impact of a raised body mass index on breast cancer survival in relation to age and disease extent at diagnosis. Breast J. 16:156-61
45. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J. Clin. 61:69-90
46. Jemal A, Siegel R, Xu J, Ward E. 2010. Cancer statistics, 2010. CA Cancer J. Clin. 60:277-300
47. Kaaks R, Lukanova A. 2001. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc. Nutr. Soc. 60:91-106 (Pubitemid 32183103)
48. Kalata P, Martus P, Zettl H, Rodel C, Hohenberger W, et al. 2009. Differences between clinical trial participants and patients in a population-based registry: the German Rectal Cancer Study versus the Rostock Cancer Registry. Dis. Colon Rectum 52:425-37
49. Kim HS, Moreira DM, Smith MR, Presti JC, Aronson WJ, et al. 2011. A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int. 107:924-28
50. Kroenke CH, Chen WY, Rosner B, Holmes MD. 2005. Weight, weight gain, and survival after breast cancer diagnosis. J. Clin. Oncol. 23:1370-78
51. Kwaan HC, Wang J, Svoboda K, Declerck PJ. 2000. Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis. Br. J. Cancer 82:1702-8 (Pubitemid 30229582)
52. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinson E, et al. 1999. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol. Endocrinol. 5:153-65
53. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, et al. 1998. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 18:928-33 (Pubitemid 28272587)
54. Lind MJ, Margison JM, Cerny T, Thatcher N, Wilkinson PM. 1989. Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution. Cancer Chemother. Pharmacol. 25:139-42 (Pubitemid 20009443)
55. Littman AJ, Koepsell TD, Forsberg CW, Boyko EJ, YancyWS Jr. 2011. Preventive care in relation to obesity: an analysis of a large, national survey. Am. J. Prev. Med. 41:465-72
56. Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, et al. 2005. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol. Biomarkers Prev. 14:1686-91 (Pubitemid 40995080)
57. Ma J, Li H, Giovannucci E, Mucci L, Qiu W, et al. 2008. Prediagnostic body-mass index, plasma Cpeptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 9:1039-47
58. MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. 2003. Body size and composition and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev. 12:1417-21 (Pubitemid 38031743)
59. Madarnas Y, Sawka CA, Franssen E, Bjarnason GA. 2001. Are medical oncologists biased in their treatment of the large woman with breast cancer? Breast Cancer Res. Treat. 66:123-33 (Pubitemid 32521418)
60. Maehle BO, Tretli S. 1996. Pre-morbid body-mass-index in breast cancer: reversed effect on survival in hormone receptor negative patients. Breast Cancer Res. Treat. 41:123-30 (Pubitemid 26360141)
61. Maehle BO, Tretli S, Thorsen T. 2004. The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status. APMIS 112:349-57 (Pubitemid 39318190)
62. Makari-Judson G, Judson CH, Mertens WC. 2007. Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year. Breast J. 13:258-65 (Pubitemid 46663153)
63. Marret H, Perrotin F, Bougnoux P, Descamps P, Hubert B, et al. 2001. Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer. Breast Cancer Res. Treat. 66:17-23 (Pubitemid 32397938)
64. Martnez ME, Giovannucci E, Spiegelman D, Willett WC, Hunter DJ, Colditz GA. 1997. Leisure-time physical activity, body size, and colon cancer in women. J. Natl. Cancer Inst. 89:948-55 (Pubitemid 27282067)
65. McTiernan A, Irwin M, Vongruenigen V. 2010. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J. Clin. Oncol. 28:4074-80
66. Meric-Bernstam F, Gonzalez-Angulo AM. 2009. Targeting the mTOR signaling network for cancer therapy. J. Clin. Oncol. 27:2278-87
67. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB, et al. 2003. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98:484-95 (Pubitemid 36885987)
68. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, et al. 2008. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J. Clin. Oncol. 26:4109-15
69. Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, et al. 2004. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J. Clin. Oncol. 22:648-57 (Pubitemid 41095068)
70. Mohle-Boetani JC, Grosser S, Whittemore AS, Malec M, Kampert JB, Paffenbarger RS Jr. 1988. Body size, reproductive factors, and breast cancer survival. Prev. Med. 17:634-42 (Pubitemid 19018369)
71. Moon HG, Han W, Noh DY. 2009. Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society. J. Clin. Oncol. 27:5899-905
72. Mosher CE, Sloane R, Morey MC, Snyder DC, Cohen HJ, et al. 2009. Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors. Cancer 115:4001-9
73. Newman SC, Lees AW, Jenkins HJ. 1997. The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int. J. Epidemiol. 26:484-90 (Pubitemid 27267767)
74. NicholsHB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, et al. 2009. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol. Biomarkers Prev. 18:1403-9
75. Obermair A, Kurz C, Hanzal E, Bancher-Todesca D, Thoma M, et al. 1995. The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Res. 15:2265-69 (Pubitemid 26031310)
76. Park J-W, Kim W-H, Shin S-H, Kim JY, Yun MR, et al. 2011. Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway. Biochim. Biophys. Acta 1813:763-71
77. Parry C, Kent EE, Mariotto AB, AlfanoCM, Rowland JH. 2011. Cancer survivors: a booming population. Cancer Epidemiol. Biomarkers Prev. 20:1996-2005
78. Pekmezi DW, Demark-Wahnefried W. 2011. Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol. 50:167-78
79. Peppercorn JM, Weeks JC, Cook EF, Joffe S. 2004. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363:263-70 (Pubitemid 38142408)
80. Perks CM, Holly JMP. 2011. Hormonal mechanisms underlying the relationship between obesity and breast cancer. Endocrinol. Metab. Clin. North Am. 40:485-507
81. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, et al. 2006. Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl. Cancer Inst. 98:920-31 (Pubitemid 44018922)
82. Pittas AG, Joseph NA, Greenberg AS. 2004. Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 89:447-52 (Pubitemid 38269842)
83. Powis G, Reece P, Ahmann DL, Ingle JN. 1987. Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients. Cancer Chemother. Pharmacol. 20:219-22 (Pubitemid 17163398)
84. Prizment AE, Flood A, Anderson KE, Folsom AR. 2010. Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study. Cancer Epidemiol. Biomarkers Prev. 19:2229-37
85. Protani M, Coory M, Martin JH. 2010. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res. Treat. 123:627-35
86. Reeves KW, Faulkner K, Modugno F, Hillier TA, Bauer DC, et al. 2007. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures. Cancer Epidemiol. Biomarkers Prev. 16:1468-73 (Pubitemid 47076880)
87. Renehan AG, Roberts DL, Dive C. 2008. Obesity and cancer: pathophysiological and biological mechanisms. Arch. Physiol. Biochem. 114:71-83 (Pubitemid 351998746)
88. Ries LAG, MelbertD, Krapcho M, Mariotto A, Miller BA, et al, eds. 2007. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: Natl. Cancer Inst.
89. Roberts DL, Dive C, Renehan AG. 2010. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu. Rev. Med. 61:301-16
90. Robison LL, Demark-Wahnefried W. 2011. Cancer survivorship: focusing on future research opportunities. Cancer Epidemiol. Biomarkers Prev. 20:1994-95
91. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, et al. 2007. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II NutritionCohort. Cancer Epidemiol. Biomarkers Prev. 16:63-69 (Pubitemid 46174265)
92. Rodvold KA, Rushing DA, Tewksbury DA. 1988. Doxorubicin clearance in the obese. J. Clin. Oncol. 6:1321-27
93. Rose DP, Komninou D, Stephenson GD. 2004. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes. Rev. 5:153-65 (Pubitemid 38998240)
94. Rosenberg L, Czene K, Hall P. 2009. Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy? Br. J. Cancer 100:1486-9196.
95. Russo A, Franceschi S, La Vecchia C, Dal Maso L, Montella M, et al.1998. Body size and colorectalcancer risk. Int. J. Cancer 78:161-65
96. Senie RT, Rosen PP, Rhodes P, LesserML, Kinne DW. 1992. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann. Intern. Med. 116:26-32
97. Sestak I, Distler W, Forbes JF, Dowsett M, Howell A, Cuzick J. 2010. Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. J. Clin. Oncol. 28:3411-15
98. Sharma D, Saxena NK, Vertino PM, Anania FA. 2006. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr. Relat. Cancer 13:629-40 (Pubitemid 43886682)
99. Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, et al. 2006. Obesity and survival after radical prostatectomy: a 10-year prospective cohort study. Cancer 107:521-29 (Pubitemid 44107212)
100. Siegel R, Ward E, Brawley O, Jemal A. 2011. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61:212-36
101. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. 2010. Obesity is an independent prognostic variable in colon cancer survivors. Clin. Cancer Res. 16:1884-93
102. Tao MH, Shu XO, Ruan ZX, Gao YT, Zheng W. 2006. Association of overweight with breast cancer survival. Am. J. Epidemiol. 163:101-7 (Pubitemid 43068978)
103. van Roermund JG, Hinnen KA, Battermann JJ, Witjes JA, Bosch JL, et al. 2010. Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy. BJU Int. 105:42-48
104. Wauters M, Considine RV, Yudkin JS, Peiffer F, De Leeuw I, Van Gaal LF. 2003. Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm. Metab. Res. 35:92-96 (Pubitemid 36583680)
105. Wei EK, Wolin KY, Colditz GA. 2010. Time course of risk factors in cancer etiology and progression. J. Clin. Oncol 28:4052-57
106. Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. 2005. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol. Biomarkers Prev. 14:2009-14 (Pubitemid 41161216)
107. World Cancer Res. Fund/Am. Inst. Cancer Res. 2007. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: Am. Inst. Cancer Res.
108. World Cancer Res. Fund/Am. Inst. Cancer Res. 2010. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer. Washington, DC: Am. Inst. Cancer Res.
109. World Cancer Res. Fund/Am. Inst. Cancer Res. 2011. Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer. Washington, DC: Am. Inst. Cancer Res.
110. Wright ME, Chang S-C, Schatzkin A, Albanes D, Kipnis V, et al. 2007. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109:675-84 (Pubitemid 46233228)
111. Yabroff KR, Lund J, Kepka D, Mariotto A. 2011. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol. Biomarkers Prev. 20:2006-14
112. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. 1999. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19:972-78 (Pubitemid 29177345)